Progenics Pharma (PGNX) Posts Q4 Loss of 14c/Share

March 13, 2014 7:42 AM

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q4 EPS of ($0.14) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found